Skip to main content
. 2019 Jan 17;60(2):216–222. doi: 10.3349/ymj.2019.60.2.216

Table 2. Bacterial and Viral Pathogen Identification according to GOLD Stage.

All events (n=736) GOLD I (n=57) GOLD II (n=281) GOLD III (n=307) GOLD IV (n=91) p value
Only bacterial identification 200 (27.2) 11 (19.3) 68 (24.2) 91 (29.6) 30 (33.0) 0.020
Only viral identification 159 (21.6) 16 (28.1) 68 (24.2) 60 (19.5) 15 (16.5) 0.031
Bacterial-viral co-identification 107 (14.5) 4 (7.0) 37 (13.2) 53 (17.3) 13 (14.3) 0.112
No identification 270 (36.7) 26 (45.6) 108 (38.4) 103 (33.6) 33 (36.3) 0.141
Pseudomonas aeruginosa 96 (13.0) 4 (7.0) 29 (10.3) 47 (15.3) 16 (17.6) 0.011
Streptococcus pneumoniae 84 (11.4) 3 (5.3) 29 (10.3) 38 (12.4) 14 (15.4) 0.048
Haemophilus influenzae 39 (5.3) 5 (8.8) 15 (5.3) 17 (5.5) 2 (2.2) 0.158
Staphylococcus aureus 35 (4.8) 1 (1.8) 16 (5.7) 10 (3.3) 8 (8.8) 0.333
Klebsiella pneumoniae 20 (2.7) 1 (1.8) 10 (3.6) 8 (2.6)1 1 (1.1) 0.509
Influenza virus 91 (12.4) 8 (14.0) 42 (14.9) 32 (10.4) 9 (9.9) 0.112
Rhinovirus 69 (9.4) 5 (8.8) 21 (7.5) 35 (11.4) 8 (8.8) 0.387
Parainfluenza virus 38 (5.2) 2 (3.5) 13 (4.6) 15 (4.9) 8 (8.8) 0.165
Metapneumovirus 36 (4.9) 3 (5.3) 14 (5.0) 15 (4.9) 4 (4.4) 0.832

GOLD, Global Initiative for Chronic Obstructive Lung Disease.

Data are presented as n (%).